GLP-1s confer better glycemic, CV outcomes than metformin

Coverage, in order

1. 5d ago
   
   Healio indie

   GLP-1s confer better glycemic, CV outcomes than metformin

   CHICAGO — Among adults with prediabetes and obesity, those taking a GLP-1 receptor agonist were more likely to achieve normoglycemia compared with those taking metformin, researchers reported. Those taking a GLP-1 were also had reduced risk for death, CV outcomes and progression to type 2 diabetes…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.